News
23mon MSN
Glenmark, Alembic Pharma, Sun Pharma shares slip up to 1.5% on product recalls after USFDA action
Glenmark Pharmaceuticals, Alembic Pharmaceuticals, and Sun Pharmaceutical Industries experienced a stock decline following ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback